Company Profiles

driven by the PitchBook Platform

Opal Therapeutics

Description

Developer of immunotherapy. The company develops therapeutic vaccines for the treatment of HIV and Hepatitis C.

2005

Founded

PRIVATE

Status

Series A

Latest Deal Type

$6M

Latest Deal Amount

$6M

Total Amount Raised

4

Investors

Description

Developer of immunotherapy. The company develops therapeutic vaccines for the treatment of HIV and Hepatitis C.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Primary Office

Melbourne, Victoria Australia
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Opal Therapeutics's full profile, request a free trial.

    Opal Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Opal Therapeutics Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Alloy VenturesVenture CapitalMinority000 0000000 0000
    Alta PartnersVenture CapitalMinority000 0000000 0000
    GBS Venture PartnersVenture CapitalMinority000 0000000 0000
    UniseedVenture CapitalMinority000 0000000 0000
    Alloy Ventures Venture Capital
    Alta Partners Venture Capital
    GBS Venture Partners Venture Capital
    Uniseed Venture Capital

    Opal Therapeutics Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Stephen KentFounder
    Stephen Kent Founder

    Opal Therapeutics Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Daniel JanneyAlta PartnersManaging Director000 0000
    Leighton Read MDAlloy VenturesVenture Partner000 0000
    Daniel Janney Managing Director Alta Partners
    Leighton Read MD Venture Partner Alloy Ventures
    Request full access to PitchBook